Literature DB >> 25805655

Silent brain infarcts in two patients with zeta chain-associated protein 70 kDa (ZAP70) deficiency.

H Haluk Akar1, Turkan Patiroglu2, Basak N Akyildiz3, Nazan U Tekerek3, M Sait Doğan4, Selim Doğanay4, Mirjam van der Burg5, Ruhan Dusunsel6.   

Abstract

Zeta-chain associated protein 70 kDa deficiency (ZAP70) is a form of severe combined immunodeficiency (SCID). It is caused by defects in the signaling pathways associated with T-lymphocyte activation. ZAP70 deficiency is characterized by a marked reduction in peripheral CD8+ T-cells. In this report, we described two patients with ZAP70 deficiency who presented with recurrent infections, lung tuberculosis (TBC), congenital nephrotic syndrome (CNS), and silent brain infarcts (SBIs) as a common feature. The first patient initially presented with recurrent infections and TBC as in a classic SCID patient. At the age of 4, he was interned with febrile seizure. Cranial magnetic resonance imaging (MRI) showed SBIs. The second patient, an 8-month-old boy, presented with congenital nephrotic syndrome caused by cytomegalovirus (CMV) and he had also SBIs.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Congenital nephrotic syndrome; Silent brain infarcts; ZAP70 deficiency

Mesh:

Substances:

Year:  2015        PMID: 25805655     DOI: 10.1016/j.clim.2015.03.014

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  5 in total

1.  An infant with ZAP-70 deficiency with disseminated mycobacterial disease.

Authors:  Saliha Esenboga; Deniz Cagdas Ayvaz; Pinar Gur Cetinkaya; Mirjam van der Burg; İlhan Tezcan
Journal:  J Clin Immunol       Date:  2015-12-28       Impact factor: 8.317

2.  Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for ZAP70 Deficiency.

Authors:  Geoffrey D E Cuvelier; Tamar S Rubin; Donna A Wall; Marlis L Schroeder
Journal:  J Clin Immunol       Date:  2016-07-20       Impact factor: 8.542

3.  A novel human autoimmune syndrome caused by combined hypomorphic and activating mutations in ZAP-70.

Authors:  Alice Y Chan; Divya Punwani; Theresa A Kadlecek; Morton J Cowan; Jean L Olson; Erin F Mathes; Uma Sunderam; Shu Man Fu; Rajgopal Srinivasan; John Kuriyan; Steven E Brenner; Arthur Weiss; Jennifer M Puck
Journal:  J Exp Med       Date:  2016-01-18       Impact factor: 14.307

4.  Clinical, Immunological, and Genetic Features in 49 Patients With ZAP-70 Deficiency: A Systematic Review.

Authors:  Niusha Sharifinejad; Mahnaz Jamee; Majid Zaki-Dizaji; Bernice Lo; Mohammadreza Shaghaghi; Hamed Mohammadi; Farhad Jadidi-Niaragh; Shiva Shaghaghi; Reza Yazdani; Hassan Abolhassani; Asghar Aghamohammadi; Gholamreza Azizi
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

5.  Combined immunodeficiencies: twenty years experience from a single center in Turkey.

Authors:  H Haluk Akar; Turkan Patiroglu; Michael Hershfield; Mirjam van der Burg
Journal:  Cent Eur J Immunol       Date:  2016-01-20       Impact factor: 2.085

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.